Articles tagged with: Women

Nov05

Yaso Therapeutics Yaso-GEL promises to prevent pregnancy and STIs and fill an unmet need in the market

Monday, 05 November 2018 Written by // Mary Weitzel, Barbara North Series // From the Pipeline Tags // contraceptive, STIs, women

We at Yaso Therapeutics are developing a vaginal gel, called Yaso-GEL, that uses a single proprietary drug to prevent pregnancy as well as genital herpes, gonorrhea, and chlamydia. The gel is mucoadhesive, non-irritating, relatively low-cost, and stable. Yaso-GEL aims to be an MPT that can fill the need for non-hormonal contraceptives and protect women from sexually transmitted infections (STIs).

Aug01

FROM THE PIPELINE | Taking on a challenge – How an ambitious engineering goal led to an innovative MPT for HIV, HSV, and unintended pregnancy

Wednesday, 01 August 2018 Written by // Meredith Roberts Clark, Kathleen Dietz Series // From the Pipeline Tags // challenge, clinical study, intravaginal ring, women

It all started with the simple realization that women seeking protection against HIV also want to prevent unintended pregnancies. In general, they also prefer a combined method. Then followed the innovation challenge: Engineer a long-acting intravaginal ring that could release two chemically diverse drugs – one for HIV and herpes simplex virus (HSV) prevention, and one for contraception – at sustained, controlled, and yet extremely different release rates (up to 1000-fold) for 3 months; make it suitable and scalable for use in resource-limited countries, such as those of sub-Saharan Africa; and design it so women would want to use it. Even now it’s a daunting task. When this project began, 10 years ago, its feasibility was questioned by many, including our collaborators and ourselves. However, if successful, this challenge had strong potential to provide a truly game-changing MPT solution to a dire unmet need for women globally.

Jun08

Women around the world lack access to comprehensive contraception—this is the solution

Friday, 08 June 2018 Written by // Bethany Young Holt Tags // contraception, HIV, prevention, product, STIs, women

In the early 1990’s, I met a young woman named Gelete. I was working as part of an HIV prevention team along the Sudanese border of Ethiopia, and Gelete was one of our team’s most committed local volunteers working to implement our condom distribution program. Growing up, she dreamed of becoming a physician and attending medical school—but, at age 16, she was raped by her teacher, became pregnant and was then ostracized and abandoned by her own family. With no support and a baby to feed, she moved to a small town to work on a coffee plantation. Since coffee bean harvesting is seasonal work with few other opportunities available in the off season, Gelete joined other young women in similar situations exchanging money for sex to survive.

Apr19

If you like it, put a ring in it! The intravaginal ring that may soon be a life changer in the sexual and reproductive health arena

Thursday, 19 April 2018 Written by // Everlyne Ombati Tags // contraception, end-user, HIV, reproductive health, SRH, STIs, vaginal ring, women

Yes! Yes! We soon may have a ring for our vaginas! I know what you are thinking; vaginal rings have been here since sliced bread. True, but what’s new about this one is that it will provide protection from HIV. Future rings will also include protection from unintended pregnancies and other sexually transmitted infections (STIs), too. And when that ring is available, I am putting it in! Because I like my vagina, and I want to stay healthy.

Apr03

FROM THE PIPELINE | Why women-centered MPT development matters

Tuesday, 03 April 2018 Written by // Martha Brady, Maggie Kilbourne-Brook Series // From the Pipeline Tags // HIV, MAP, PATH, pipeline, prevention, product, protection, reproductive health, SRH, STIs, women

Incorporating what women want into new sexual and reproductive health products is essential

We at PATH make it our business to reflect on the elusive topic of ‘what women want’—in terms of protection options in their sexual and reproductive lives. Not surprisingly, the answer is complex. Women want and need different things at different stages of their lifecycle, depending on the circumstances of their lives.

[12 3  >>  

Share

Spread the word about the promise of MPTs.

Collaborate

We will go further together – join the movement for MPTs.

Contribute

Your financial and in-kind support can help make MPTs a reality.